Authors:
Sabetkar, M
Naseem, KM
Tullett, JM
Friebe, A
Koesling, D
Bruckdorfer, KR
Citation: M. Sabetkar et al., Synergism between nitric oxide and hydrogen peroxide in the inhibition of platelet function: The roles of soluble guanylyl cyclase and vasodilator-stimulated phosphoprotein, NITRIC OXID, 5(3), 2001, pp. 233-242
Authors:
Naseem, KM
Low, SY
Sabetkar, M
Bradley, NJ
Khan, J
Jacobs, M
Bruckdorfer, KR
Citation: Km. Naseem et al., The nitration of platelet cytosolic proteins during agonist-induced activation of platelets, FEBS LETTER, 473(1), 2000, pp. 119-122
Authors:
Naseem, KM
Mumtaz, FH
Thompson, CS
Sullivan, ME
Khan, MA
Morgan, RJ
Mikhailidis, DP
Bruckdorfer, KR
Citation: Km. Naseem et al., Relaxation of rabbit lower urinary tract smooth muscle by nitric oxide andcarbon monoxide: modulation by hydrogen peroxide, EUR J PHARM, 387(3), 2000, pp. 329-335
Authors:
Denton, CP
Bunce, TD
Dorado, MB
Roberts, Z
Wilson, H
Howell, K
Bruckdorfer, KR
Black, CM
Citation: Cp. Denton et al., Probucol improves symptoms and reduces lipoprotein oxidation susceptibility in patients with Raynaud's phenomenon, RHEUMATOLOG, 38(4), 1999, pp. 309-315
Authors:
Ettelaie, C
Wilbourn, BR
Adam, JM
James, NJ
Bruckdorfer, KR
Citation: C. Ettelaie et al., Comparison of the inhibitory effects of ApoB100 and tissue factor pathway inhibitor on tissue factor and the influence of lipoprotein oxidation, ART THROM V, 19(7), 1999, pp. 1784-1790
Citation: Km. Naseem et Kr. Bruckdorfer, The influence of organic peroxides on platelet aggregation and sensitivityto nitric oxide, PLATELETS, 10(2-3), 1999, pp. 146-152
Authors:
Mumtaz, FH
Sullivan, ME
Thompson, CS
Dashwood, MR
Naseem, KM
Bruckdorfer, KR
Mikhailidis, DP
Morgan, RJ
Citation: Fh. Mumtaz et al., Alterations in the nitric oxide synthase binding sites and non-adrenergic,non-cholinergic mediated smooth muscle relaxation in the diabetic rabbit bladder outlet: Possible relevance to the pathogenesis of diabetic cystopathy, J UROL, 162(2), 1999, pp. 558-566
Citation: L. Mabile et al., Moderate supplementation with natural alpha-tocopherol decreases platelet aggregation and low-density lipoprotein oxidation, ATHEROSCLER, 147(1), 1999, pp. 177-185
Authors:
Ettelaie, C
Adam, JM
James, NJ
Oke, AO
Harrison, JA
Bunce, TD
Bruckdorfer, KR
Citation: C. Ettelaie et al., The role of the C-terminal domain in the inhibitory functions of tissue factor pathway inhibitor, FEBS LETTER, 463(3), 1999, pp. 341-344